Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 3,876 $ 4,455
Accounts receivable, net 4,340 4,354
Inventories, net 5,201 6,611
Prepaid expenses and other current assets 1,169 812
Total Current Assets 14,586 16,232
Fixed assets, net 198 230
Right-of-use assets, operating leases 106 120
Goodwill 405
Other assets 149 155
Total Assets 15,444 16,737
Current Liabilities    
Accounts payable 7,478 6,928
Accrued and other liabilities 1,505 2,085
Line of credit 2,171 1,741
Term loan, net 3,054 2,881
Operating lease liability 58 57
Total Current Liabilities 14,266 13,692
Non-current Liabilities    
Operating lease liability 52 67
Total Non-current Liabilities 52 67
Total Liabilities 14,318 13,759
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 823,650 & 729,026 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 34 32
Additional paid-in capital 325,264 324,288
Accumulated deficit (324,172) (321,342)
Total Stockholders’ Equity 1,126 2,978
Total Liabilities and Stockholders’ Equity $ 15,444 $ 16,737